Hemophilia B, an X-linked disorder, is ideally suited for gene therapy. We investigated the use of a new gene therapy in patients with the disorder. We infused a single dose of a ...
Nine-year follow-up of gene therapy in haemophilia B confirms long-term safety and reduced bleeding, though full capsid ...
Hemophilia B gene therapy reduced bleeding and supported lasting clotting levels, even in some patients with antibodies, new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results